Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of British Columbia

$59,000.00

Synthesis of Complex Natural Products

EF 2015-16

Résumé
The immediate goal of our research is to develop innovative, environmentally benign methods for the synthesis of nitrogenous substances, and to apply them to the total synthesis of complex natural products. This entails the exploration of uncharted strategies that often lead to more efficient routes. We wish to pursue the above general objective in connection with: (i) a synthesis of nosiheptide that rests a new route to the pyridine-thiazole cluster of the molecule; (ii) the further development of oxidative amidation of phenols through the synthesis of (-)-tetrodotoxin and (-)-himandrin, the scouting of new routes to Amaryllidaceae and Cephalotaxus alkaloids and grandilodine A, and the optimization of an enantioselective variant of the chemistry; (iii) the completion of the synthesis of diazonamide B and telomestatin through new oxazole-forming chemistry; (iv) the completion of syntheses of cyanocyclin and quinocarcin that rest on late introduction of aromatic/quinoid segments on a complex aminoacid that is readily made from pyroglutamic ester. All of the above efforts illustrate new strategic principles that should greatly simplify the assembly of the target molecules, which are challenging and have eluded many established researchers. The successful realization of the vision contained in this proposal will command significant attention from the chemical community, advance the state of the art of synthetic heterocyclic chemistry, and enhance the reputation of UBC and of Canadian chemistry. The results that are likely to emanate from this work are applicable to manufacturing processes: indeed, techniques devised in this laboratory in the past have been incorporated in current industrial syntheses of a number of pharmaceuticals. Many aspects of the proposed research are relevant to UBC's Center for Drug Research and Development (in which the PI served as co-head of the chemistry division) and the pharmaceutical industry, which will also be a beneficiary of the HQP trained through this program. Our long-term objective is to translate knowledge emanating from curiosity-driven research into new chemotherapeutic agents. Indeed, a number of experimental medicines created in this laboratory in collaboration with the public and private sector are currently undergoing clinical evaluation in humans. Although no NSERC funds were ever used to support the research that produced such medicines, aspects of the knowledge accumulated during fundamental research efforts was key to the development of the foregoing drugs.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2015-03775
Name nom
Ciufolini, Marco
Department département
Chemistry - Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
59000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
5
Application title
Synthesis of Complex Natural Products
Keyword
NSERC
Application summary
<p>The immediate goal of our research is to develop innovative, environmentally benign methods for the synthesis of nitrogenous substances, and to apply them to the total synthesis of complex natural products. This entails the exploration of uncharted strategies that often lead to more efficient routes. We wish to pursue the above general objective in connection with: (i) a synthesis of nosiheptide that rests a new route to the pyridine-thiazole cluster of the molecule; (ii) the further development of oxidative amidation of phenols through the synthesis of (-)-tetrodotoxin and (-)-himandrin, the scouting of new routes to Amaryllidaceae and Cephalotaxus alkaloids and grandilodine A, and the optimization of an enantioselective variant of the chemistry; (iii) the completion of the synthesis of diazonamide B and telomestatin through new oxazole-forming chemistry; (iv) the completion of syntheses of cyanocyclin and quinocarcin that rest on late introduction of aromatic/quinoid segments on a complex aminoacid that is readily made from pyroglutamic ester. All of the above efforts illustrate new strategic principles that should greatly simplify the assembly of the target molecules, which are challenging and have eluded many established researchers. The successful realization of the vision contained in this proposal will command significant attention from the chemical community, advance the state of the art of synthetic heterocyclic chemistry, and enhance the reputation of UBC and of Canadian chemistry. The results that are likely to emanate from this work are applicable to manufacturing processes: indeed, techniques devised in this laboratory in the past have been incorporated in current industrial syntheses of a number of pharmaceuticals. Many aspects of the proposed research are relevant to UBC's Center for Drug Research and Development (in which the PI served as co-head of the chemistry division) and the pharmaceutical industry, which will also be a beneficiary of the HQP trained through this program. Our long-term objective is to translate knowledge emanating from curiosity-driven research into new chemotherapeutic agents. Indeed, a number of experimental medicines created in this laboratory in collaboration with the public and private sector are currently undergoing clinical evaluation in humans. Although no NSERC funds were ever used to support the research that produced such medicines, aspects of the knowledge accumulated during fundamental research efforts was key to the development of the foregoing drugs.</p>